Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855552 · ClinicalTrials.gov registry record · NA

Telehealth Weight Loss Program for Breast Cancer Survivors

A NA study of Overweight and Obesity and Body Weight, sponsored by Abramson Cancer Center at Penn Medicine.

Active
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT04855552: Active NA study of Overweight and Obesity and Body Weight, sponsored by Abramson Cancer Center at Penn Medicine.

NCT04855552 is a NA study of Overweight and Obesity and Body Weight that is active but no longer recruiting, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 22 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855552, a NA study of Overweight and Obesity and Body Weight, is active but no longer recruiting, sponsored by Abramson Cancer Center at Penn Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.

Primary Outcome

To determine the feasibility and acceptability of a weight loss program via telehealth for breast cancer survivors. The participants will be asked to complete the City of Hope Quality of Life Instrument (COH-QOL) - Breast Cancer Patient (QOL-BC) at two time points: baseline (pre-) and treatment end (at week 24). * COH-QOL Instrument - Breast Cancer Patient (QOL-BC) - 46 items * The scoring is based on a scale of 0 = worst outcome to 10 = best outcome. Some items have reverse anchors and the val

Conditions Studied

Overweight and Obesity Body Weight Cancer Survivors Cancer of Breast

Interventions

  • BEHAVIORAL Behavioral Weight-loss Program Via Telehealth
  • BEHAVIORAL Behavioral Weight-Loss Program Via Telehealth - Weight Measures
  • BEHAVIORAL Validated Surveys of Patient-Reported Outcomes

Study Locations (1)

Pennsylvania

  • University of Pennsylvania (Hospital of the University of Pennsylvania) - Philadelphia

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-07-19
Est. Completion 2026-12
Phase NA
Abramson Cancer Center at Penn Medicine

402 total trials

What the registry record for NCT04855552 still lists

NCT04855552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (90% lower).

The record links to 4 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Behavioral Weight-loss Program Via Telehealth is the first listed.

NCT04855552 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04855552 about?

NCT04855552 is a clinical study titled "Telehealth Weight Loss Program for Breast Cancer Survivors". This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.

What is the current status of trial NCT04855552?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2021-07-19. Estimated completion is 2026-12.

What conditions does trial NCT04855552 study?

This clinical trial studies the following conditions: Overweight and Obesity, Body Weight, Cancer Survivors, Cancer of Breast.

What interventions are being tested in trial NCT04855552?

The interventions under investigation include: Behavioral Weight-loss Program Via Telehealth (BEHAVIORAL), Behavioral Weight-Loss Program Via Telehealth - Weight Measures (BEHAVIORAL), Validated Surveys of Patient-Reported Outcomes (BEHAVIORAL).

Who is sponsoring clinical trial NCT04855552?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855552 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04855552's enrollment target sits among peer trials

22 103rd of 115 higher than 13 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04855552, the US trial registry maintained by the National Library of Medicine. NCT04855552 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.